| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Case of Acute Promyelocytic Leukemia Without RARĪ± Rearrangement and Apparently Normal Cytogenetics
|
Vaklavas, Christos
|
|
2011
|
11 |
6 |
p. 521-524
4 p.
|
article
|
| 2 |
A Prospective Phase II Study of RICE Re-Induction, Then High-Dose Fludarabine and Busulfan, Followed by Autologous or Allogeneic Blood Stem Cell Transplantation for Indolent B-Cell Lymphoma. ClinicalTrials.gov ID: NCT00144092
|
Stewart, Douglas A.
|
|
2011
|
11 |
6 |
p. 475-482
8 p.
|
article
|
| 3 |
Clinical Outcomes of Patients With Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: A Single-Institution Experience
|
Lebovic, Daniel
|
|
2011
|
11 |
6 |
p. 507-511
5 p.
|
article
|
| 4 |
Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial
|
Zinzani, Pier Luigi
|
|
2011
|
11 |
6 |
p. 462-466
5 p.
|
article
|
| 5 |
Cutaneous and Systemic Plasmacytosis vs. Cutaneous Plasmacytic Castleman Disease: Review and Speculations About Pathogenesis
|
Haque, Maryam
|
|
2011
|
11 |
6 |
p. 453-461
9 p.
|
article
|
| 6 |
EBV-Positive Diffuse Large B-Cell Lymphoma in Young Immunocompetent Individuals
|
Beltran, Brady E.
|
|
2011
|
11 |
6 |
p. 512-516
5 p.
|
article
|
| 7 |
Editorial Board/Masthead
|
|
|
2011
|
11 |
6 |
p. A8-
1 p.
|
article
|
| 8 |
Interstitial Pneumonia After Autologous Hematopoietic Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphoma
|
Kato, Harumi
|
|
2011
|
11 |
6 |
p. 483-489
7 p.
|
article
|
| 9 |
Multiple Myeloma Associated IgA Pemphigus: Treatment With Bortezomib- and Lenalidomide-Based Regimen
|
Szturz, Petr
|
|
2011
|
11 |
6 |
p. 517-520
4 p.
|
article
|
| 10 |
Racial Differences in the Presentation and Outcomes of Chronic Lymphocytic Leukemia and Variants in the United States
|
Shenoy, Pareen J.
|
|
2011
|
11 |
6 |
p. 498-506
9 p.
|
article
|
| 11 |
Ribosomal Protein Metallopanstimulin-1 Impairs Multiple Myeloma CAG Cells Growth and Inhibits Fibroblast Growth Factor Receptor 3
|
Dai, Yuemeng
|
|
2011
|
11 |
6 |
p. 490-497
8 p.
|
article
|
| 12 |
Safety and Efficacy of Combination Therapy with Fludarabine, Mitoxantrone, and Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan and Maintenance Rituximab as Front-Line Therapy for Patients With Follicular or Marginal Zone Lymphoma
|
Karmali, Reem
|
|
2011
|
11 |
6 |
p. 467-474
8 p.
|
article
|
| 13 |
Table of Contents
|
|
|
2011
|
11 |
6 |
p. A11-A12
nvt p.
|
article
|
Journal description